ETH spin-off Immitra Bio gets $168,000 from Venture Kick for rare genetic disease treatment
Summary
Immitra Bio, an ETH spin-off, received $168,000 from Venture Kick. The funding supports work on a treatment for a rare genetic disease. This is an early-stage financing event rather than a product or acquisition announcement. The company sits in the life sciences and health tech space, so the news is relevant to software and digital health audiences only at a broad industry level.
Funding
Amount
$168.0K
Total raised
Date
June 15, 2026
Announcement date
Investors
The Chen Group, VentureKick
Lead investors
Company
immitra.bio
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected